title: Lamivudine transiently reduces viral load and improves liver function in liver transplant recipients with fibrosing cholestatic hepatitis.
authors.forename: Hans L
authors.initials: HL
authors.lastname: Tillmann
authors.forename: Christian
authors.initials: C
authors.lastname: Trautwein
authors.forename: C Thomas
authors.initials: CT
authors.lastname: Bock
authors.forename: Isabella
authors.initials: I
authors.lastname: Glomb
authors.forename: Martin
authors.initials: M
authors.lastname: Krüger
authors.forename: Klaus H W
authors.initials: KH
authors.lastname: Böker
authors.forename: Jürgen
authors.initials: J
authors.lastname: Klempnauer
authors.forename: Peer
authors.initials: P
authors.lastname: Flemming
authors.forename: Michael P
authors.initials: MP
authors.lastname: Manns
mesh_terms: D002779:Cholestasis / Q000503:physiopathology* / Q000601:surgery*; D006505:Hepatitis / Q000503:physiopathology* / Q000601:surgery*; D006801:Humans; D019259:Lamivudine / Q000494:pharmacology*; D008099:Liver / Q000187:drug effects* / Q000503:physiopathology*; D008103:Liver Cirrhosis / Q000503:physiopathology* / Q000601:surgery*; D016031:Liver Transplantation; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology*; D019562:Viral Load
chemical_list: D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine